Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
$7.60
+3.4%
$8.47
$3.75
$11.54
$158.84M2.6388,128 shs9,727 shs
Inhibikase Therapeutics, Inc. stock logo
IKT
Inhibikase Therapeutics
$1.69
+4.0%
$1.66
$1.15
$4.20
$125.56M0.89179,495 shs23,166 shs
Lifevantage Corporation stock logo
LFVN
Lifevantage
$9.28
+0.3%
$11.98
$9.19
$27.38
$117.76M0.26191,159 shs15,740 shs
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
$0.18
-2.0%
$0.22
$0.14
$0.68
$34.36M0.7816,998 shs59,360 shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
-0.68%+12.90%-17.42%-31.94%+734,999,900.00%
Inhibikase Therapeutics, Inc. stock logo
IKT
Inhibikase Therapeutics
0.00%0.00%-2.99%-19.80%+29.60%
Lifevantage Corporation stock logo
LFVN
Lifevantage
-2.73%-4.93%-23.62%-29.17%-20.80%
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
-2.03%+7.76%-3.63%-47.58%-71.02%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
$7.60
+3.4%
$8.47
$3.75
$11.54
$158.84M2.6388,128 shs9,727 shs
Inhibikase Therapeutics, Inc. stock logo
IKT
Inhibikase Therapeutics
$1.69
+4.0%
$1.66
$1.15
$4.20
$125.56M0.89179,495 shs23,166 shs
Lifevantage Corporation stock logo
LFVN
Lifevantage
$9.28
+0.3%
$11.98
$9.19
$27.38
$117.76M0.26191,159 shs15,740 shs
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
$0.18
-2.0%
$0.22
$0.14
$0.68
$34.36M0.7816,998 shs59,360 shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
-0.68%+12.90%-17.42%-31.94%+734,999,900.00%
Inhibikase Therapeutics, Inc. stock logo
IKT
Inhibikase Therapeutics
0.00%0.00%-2.99%-19.80%+29.60%
Lifevantage Corporation stock logo
LFVN
Lifevantage
-2.73%-4.93%-23.62%-29.17%-20.80%
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
-2.03%+7.76%-3.63%-47.58%-71.02%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
3.00
Buy$20.00163.16% Upside
Inhibikase Therapeutics, Inc. stock logo
IKT
Inhibikase Therapeutics
2.50
Moderate Buy$6.50285.76% Upside
Lifevantage Corporation stock logo
LFVN
Lifevantage
2.67
Moderate Buy$30.50228.66% Upside
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest PYRGF, LFVN, IKT, and ACOG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/27/2025
Lifevantage Corporation stock logo
LFVN
Lifevantage
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C+)
(Data available from 10/8/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
N/AN/AN/AN/A$2.59 per shareN/A
Inhibikase Therapeutics, Inc. stock logo
IKT
Inhibikase Therapeutics
N/AN/AN/AN/A$1.78 per shareN/A
Lifevantage Corporation stock logo
LFVN
Lifevantage
$228.53M0.52$1.07 per share8.65$2.75 per share3.37
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
$9.14M3.76N/AN/A($0.01) per share-18.32
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
-$14.64M-$1.60N/AN/AN/A-80.16%-60.95%11/13/2025 (Estimated)
Inhibikase Therapeutics, Inc. stock logo
IKT
Inhibikase Therapeutics
-$19.03M-$2.67N/AN/AN/AN/A-350.63%-201.82%N/A
Lifevantage Corporation stock logo
LFVN
Lifevantage
$9.81M$0.7412.54N/A4.29%33.75%15.26%11/4/2025 (Estimated)
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
-$21.12M-$0.03N/AN/A-115.14%N/A-60.81%N/A

Latest PYRGF, LFVN, IKT, and ACOG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/4/2025Q1 2026
Lifevantage Corporation stock logo
LFVN
Lifevantage
$0.17N/AN/AN/A$54.74 millionN/A
9/4/2025Q4 2025
Lifevantage Corporation stock logo
LFVN
Lifevantage
$0.17$0.17N/A$0.15$57.93 million$55.11 million
8/14/2025Q2 2025
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
-$0.46-$0.65-$0.19-$0.65$2.32 million$1.66 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
N/AN/AN/AN/AN/A
Inhibikase Therapeutics, Inc. stock logo
IKT
Inhibikase Therapeutics
N/AN/AN/AN/AN/A
Lifevantage Corporation stock logo
LFVN
Lifevantage
$0.181.94%N/A24.32%3 Years
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
N/AN/AN/AN/AN/A

Latest PYRGF, LFVN, IKT, and ACOG Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/26/2025
Lifevantage Corporation stock logo
LFVN
Lifevantage
quarterly$0.04501.57%9/8/20259/8/20259/16/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
N/A
17.14
16.83
Inhibikase Therapeutics, Inc. stock logo
IKT
Inhibikase Therapeutics
N/A
0.85
0.85
Lifevantage Corporation stock logo
LFVN
Lifevantage
N/A
1.87
1.11
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
N/A
0.60
0.50

Institutional Ownership

CompanyInstitutional Ownership
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
N/A
Inhibikase Therapeutics, Inc. stock logo
IKT
Inhibikase Therapeutics
3.81%
Lifevantage Corporation stock logo
LFVN
Lifevantage
35.32%
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
0.03%

Insider Ownership

CompanyInsider Ownership
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
14.00%
Inhibikase Therapeutics, Inc. stock logo
IKT
Inhibikase Therapeutics
7.30%
Lifevantage Corporation stock logo
LFVN
Lifevantage
21.95%
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
47.68%
CompanyEmployeesShares OutstandingFree FloatOptionable
Alpha Cognition Inc. stock logo
ACOG
Alpha Cognition
N/A20.90 million17.98 millionN/A
Inhibikase Therapeutics, Inc. stock logo
IKT
Inhibikase Therapeutics
674.52 million66.18 millionNot Optionable
Lifevantage Corporation stock logo
LFVN
Lifevantage
26012.69 million9.91 millionOptionable
PyroGenesis Canada Inc. stock logo
PYRGF
PyroGenesis Canada
90187.53 million96.34 millionNo Data

Recent News About These Companies

PyroGenesis Announces Second Quarter 2025 Results
PyroGenesis Announces Extension to Term of Warrants

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Alpha Cognition stock logo

Alpha Cognition NASDAQ:ACOG

$7.60 +0.25 (+3.40%)
As of 10:47 AM Eastern

Alpha Cognition, Inc. is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.

Inhibikase Therapeutics stock logo

Inhibikase Therapeutics NYSE:IKT

$1.70 +0.08 (+5.19%)
As of 11:09 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Inhibikase Therapeutics, Inc., a clinical-stage pharmaceutical company, develops therapeutics for Parkinson's disease and related disorders. Its lead product candidate is IkT-148009, a non-receptor Abelson tyrosine kinase inhibitor, which is in Phase 2a clinical trials to the treatment of Parkinson's disease and gastrointestinal tract. The company is also developing IkT-001Pro, a prodrug of the anticancer agent imatinib mesylate to treat stable phase chronic myelogenous leukemia. Inhibikase Therapeutics, Inc. has research and development collaborations with Johns Hopkins University, Arizona State University, and Michigan State University; and a collaborative research and development agreement with Sphaera Pharma Pte. Ltd. The company was founded in 2008 and is headquartered in Atlanta, Georgia.

Lifevantage stock logo

Lifevantage NASDAQ:LFVN

$9.28 +0.03 (+0.32%)
As of 11:07 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, it offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website and network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The company was founded in 2003 and is headquartered in Lehi, Utah.

PyroGenesis Canada stock logo

PyroGenesis Canada NASDAQ:PYRGF

$0.18 0.00 (-2.03%)
As of 10/7/2025 02:55 PM Eastern

PyroGenesis Canada Inc. designs, develops, manufactures, and commercializes plasma processes and solutions worldwide. The company offers DROSRITE, a process for enhancing metal recovery from dross without any hazardous by-products; plasma atomization process that allows produce and sell high purity spherical metal powders; PUREVAP, a process to produce high purity metallurgical and solar grade silicon from quartz; and PUREVAP NSiR, which is designed to transform silicon into spherical silicon nano powders and nanowires for use in lithium-ion batteries. It provides plasma torches and plasma torch systems used toreplace fossil fuel burners in industrial iron ore pelletization process; plasma arc waste destruction systems for waste destruction onboard ships; steam plasma arc refrigerant cracking systems for the destruction of certain refrigerants, including chlorofluorocarbons, hydrofluorocarbons, and hydrochlorofluorocarbons; plasma arc chemical warfare agent destruction systems, which are mobile platforms for the onsite destruction of chemical warfare agents; plasma resource recovery systems for land-based waste destruction and waste-to-energy applications; plasma torches for waste gasification and combustion; and plasma arc gasification and vitrification. In addition, it offers engineering and manufacturing expertise, and contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, additive manufacturing (including 3D printing), oil and gas, and environmental industries. Further, the company provides installation, commissioning, and start-up services. PyroGenesis Canada Inc. is headquartered in Montreal, Canada.